< Back to previous page
Researcher
Inge Lodewijckx
- Disciplines:Systems biology
Affiliations
- Laboratory of Molecular Biology of Leukemia (VIB-KU Leuven) (Division)
Member
From18 Oct 2017 → 21 Mar 2022 - Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From15 Sep 2017 → 17 Oct 2017 - Laboratory for Tumor Microenvironment and Therapeutic Resistance (VIB-KU Leuven) (Division)
Member
From1 Sep 2016 → 14 Sep 2017
Projects
1 - 1 of 1
- Vascular and Immune Modulation in CancerFrom16 Aug 2016 → 9 Aug 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 7 of 7
- Oncogene coöperatie in T-cel acute lymfatische leukemie(2021)
Authors: Inge Lodewijckx, Jan Cools
- Oncogenic Cooperation Between IL7R-JAK-STAT Pathway Mutations(2021)
Authors: Inge Lodewijckx, Jan Cools
- Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies(2021)
Authors: Inge Lodewijckx, Jan Cools
- Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia(2019)
Authors: Michaël Broux, Cristina PRIETO FERNANDEZ, Sofie Demeyer, Marlies Vanden Bempt, Inge Lodewijckx, Roel Vandepoel, Jan Cools
Pages: 1323 - 1336 - Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition(2019)
Authors: Charles De Bock, Inge Lodewijckx, Delphine Verbeke, David Nittner, Sofie Demeyer, James Dooley, Adrian Liston, Jan Cools, Bart De Strooper
- Monocytes from patients with Primary Ciliary Dyskinesia show enhanced inflammatory properties and produce higher levels of pro-inflammatory cytokines(2017)
Authors: Maaike Cockx, Mieke Gouwy, Pieter Ruytinx, Inge Lodewijckx, Anneleen Van Hout, Jo Van Damme, Mieke Boon, Sofie Struyf
Pages: 14657 - Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation(2017)
Authors: Inge Lodewijckx, Gabriele Bergers